Live Breaking News & Updates on Bio Supplies

Stay updated with breaking news from Bio supplies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Grifols (NASDAQ:GRFS) Shares Gap Up to $8.61

Grifols, S.A. (NASDAQ:GRFS – Get Rating) shares gapped up prior to trading on Wednesday . The stock had previously closed at $8.61, but opened at $9.20. Grifols shares last traded at $9.10, with a volume of 516,956 shares traded. Wall Street Analysts Forecast Growth Several research firms have commented on GRFS. Barclays raised shares of […] ....

Morgan Stanley , Advisor Group Holdings Inc , Quadrant Capital Group , Get Rating , Financial Advisors , Group Holdings , Capital Group , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily ,

Harris Associates L P Has $21.89 Million Holdings in Grifols, S.A. (NASDAQ:GRFS)

Harris Associates L P increased its stake in Grifols, S.A. (NASDAQ:GRFS – Get Rating) by 47.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,575,400 shares of the biotechnology company’s stock after purchasing an additional 832,800 shares during the period. Harris […] ....

Gabelli Funds , Morgan Stanley , Hennion Walsh Asset Management Inc , Harris Associates , Alanb Lancz Associates Inc , Exchange Commission , Get Rating , Walsh Asset Management , Bio Supplies , Bioscience Segment , Hospital Segment , Visit Holdingschannel , Grifols Daily ,

Grifols (NASDAQ:GRFS) Trading Down 2%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) fell 2% on Tuesday . The company traded as low as $8.54 and last traded at $8.64. 98,387 shares were traded during mid-day trading, a decline of 89% from the average session volume of 899,347 shares. The stock had previously closed at $8.82. Analyst Ratings Changes A […] ....

Advisor Group Holdings Inc , Morgan Stanley , Quadrant Capital Group , Get Rating , Financial Advisors , Group Holdings , Capital Group , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily ,

Grifols, S.A. (NASDAQ:GRFS) Receives Consensus Rating of "Moderate Buy" from Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Rating) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective […] ....

Norges Bank , Morgan Stanley , First Trust Advisors , Grifols Company Profile , Get Rating , Marketbeat Ratings , Trust Advisors , Investment Partners , World Investors , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,

Grifols (NASDAQ:GRFS) Shares Gap Up to $8.34

Grifols, S.A. (NASDAQ:GRFS – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $8.34, but opened at $8.90. Grifols shares last traded at $8.88, with a volume of 45,725 shares traded. Analysts Set New Price Targets A number of research firms have recently commented on GRFS. Barclays […] ....

Ronald Blue Trust Inc , Quadrant Capital Group , Morgan Stanley , Grifols Company Profile , Susquehanna International Securities Ltd , Get Rating , Financial Advisors , Blue Trust , Capital Group , Susquehanna International Securities , Bio Supplies , Bioscience Segment , Hospital Segment , Grifols Daily , Nasdaq Grfs ,